AMGEN INC — Form D/A

AMGEN INC of Thousand Oaks, CA, a company, filed a Form D amendment with the SEC on 2012-02-29. The offering totals $2.5B. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (47)

Showing 25 of 47 people.

NameRoleLocation
David J BaltimoreDirectorThousand Oaks, CA
Frank J Biondi, Jr.DirectorThousand Oaks, CA
Robert A BradwayDirectorThousand Oaks, CA
Vance D CoffmanDirectorThousand Oaks, CA
Francois D de CarbonnelDirectorThousand Oaks, CA
Rebecca D HendersonDirectorThousand Oaks, CA
Frank C HerringerDirectorThousand Oaks, CA
Gilbert S OmennDirectorNorcross, GA
Judith C PelhamDirectorThousand Oaks, CA
J Paul ReasonDirectorThousand Oaks, CA
Leonard D SchaefferDirectorThousand Oaks, CA
Kevin W SharerDirectorThousand Oaks, CA
David W BeierExecutive OfficerThousand Oaks, CA
Fabrizio W BonanniExecutive OfficerThousand Oaks, CA
Robert A BradwayExecutive OfficerThousand Oaks, CA
Thomas J DittrichExecutive OfficerThousand Oaks, CA
Brian M McNameeExecutive OfficerThousand Oaks, CA
Jonathan M PeacockExecutive OfficerThousand Oaks, CA
Anna S RichoExecutive OfficerThousand Oaks, CA
David J ScottExecutive OfficerThousand Oaks, CA
Kevin W SharerExecutive OfficerThousand Oaks, CA
Michael A KellyExecutive OfficerPrinceton, NJ
Roger M PerlmutterExecutive OfficerHayward, CA
R. Sanders WilliamsDirectorSouth San Francisco, CA
David M PiacquadExecutive OfficerThousand Oaks, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2015-01-23D/A$2.5B
2014-01-29D/A$2.5B
2013-02-04D/A$2.5B
2011-03-14D$2.3B

More